Presented By
TEXAS ONCOLOGY
Sponsored By
CANCER INSIGHT
Thought Leaders and Innovators Came Together To Share Their Knowledge, Experience, Research, and Insights about Cancer Innovation.
Telemedicine During COVID-19 and Beyond
CaNCER DRUG SHOWCASE
Heather Leigh Flannery is the Founder and Chief Executive Officer of ConsenSys Health. She is also Co-Founder and Board Chair of Blockchain in Healthcare Global ("BiHG"), a new 501(c)6 trade association organized under the IEEE ISTO. She chairs the IEEE SA P2418.6 Standards Development Working Group (blockchain in healthcare and life sciences), serves as the FY19 and FY20 Co-Chair of the global HIMSS Blockchain in Healthcare Task Force, Chairs the Healthcare Special Interest Group at the Enterprise Ethereum Alliance (EEA), and is an Associate Editor of the peer-reviewed journal, Frontiers Blockchain for Science.
Ms. Flannery is also an Innovation Fellow at EP3 Foundation, has served as Industry Faculty for the United States Department of Health and Human Services Office of the National Coordinator for Health IT (US HHS ONC) and is an active consultant, advisor, and keynote speaker.
Prior to ConsenSys, she founded and led Obesity Prevention, Policy, and Management, Inc. ("Obesity PPM"), an innovative provider of disease management, population health, research administration, and information technology managed services for health systems in the Americas, and an early adopter of blockchain technology.
Ms. Flannery has driven business model innovation via technology early adoption throughout her 25-year career as an entrepreneur, technologist, and strategist. She has consulted in the public sector in context of international development, bringing a global health perspective to her work. Focusing in the health sector since 2006, Ms. Flannery is a broad, lateral thinker who applies complex adaptive systems thinking to make progress against macroscopic challenges.
Due to her personal life experience, Ms. Flannery is intrinsically motivated to impact population health and economic prosperity. She builds mission-driven organizations aligned by shared values: making measurable societal contributions, creating economically sustainable interventions, and prioritizing diversity and inclusion.
FEATURED SPEAKERS
Cindy WalkerPeach, PhD returned to Central Texas to lead CPRIT’s Product Development Program which critically evaluates and invests in Texas-based companies with promising novel products (drugs, diagnostics, medical devices and other non-traditional oncology applications) and services that will benefit cancer patients and society.
Prior to joining CPRIT, she served as Program Director for the National Science Foundation (NSF) Innovation Corps (I-Corps) program in Washington, DC. I-Corps prepares research scientists/engineers to extend their focus beyond the university laboratory and accelerates the economic and societal benefits of research projects with commercialization potential.
She joined NSF from the University of Texas at Austin where she was a Director at the Austin Technology Incubator, having served as lead advisor for healthcare-focused life sciences startups. She was responsible for evaluating new business ventures, managing a portfolio of bioscience startups and providing business mentoring to technology-focused faculty and entrepreneurs.
Prior to government service, Dr. WalkerPeach had more than 20 years of experience in the biotechnology sector as a member of several life science company management teams. Dr. WalkerPeach completed a BS in Chemistry and holds a PhD in Molecular Biology.
Jeff Yorio, MD., is a medical oncologist and hematologist at Texas Oncology–Austin Central. He is currently Texas Oncology’s Austin Area Physician Team Leader for melanoma and genitourinary cancer research and serves as the Chief of Hematology-Oncology at Seton Medical Center.
Dr. Yorio has also served as a national and local principal investigator for multiple clinical trials for melanoma, head and neck cancer, renal cell carcinoma, bladder cancer and prostate cancer. He strives to bring leading-edge treatments and new research to patients in Austin.
When the COVID-19 pandemic arrived in Austin, Dr. Yorio helped open a convalescent plasma therapy program using plasma donations from recovered COVID-19 patients to treat hospitalized patients with COVID-19.
Dr. Yorio received his Doctor of Medicine with Distinction in Research from The University of Texas Southwestern Medical Center, where he was also recognized for an Outstanding Clinical Research award amongst his peers in residency. He completed his Fellowship in Medical Oncology and Hematology at UT MD Anderson Cancer Center.
Bonnie Clipper, DNP is a nationally recognized expert on the future of nursing and nursing innovation, a top nurse influencer, international speaker and Amazon #1 best-selling author in six countries.
She is the chief clinical officer at Wambi, a health tech start-up mentor and was the first vice president of innovation for the American Nurses Association, where she created the innovation framework that is inspiring 4 million registered nurses to transform health through nurse-led innovation.
Prior to that Bonnie spent more than 20 years in executive nursing roles. Her research interests are nurse-led innovation, the impact of technology on nursing and amplifying the influence of nurses. Dr. Clipper is a Robert Wood Johnson Foundation Executive Nurse Fellow alumna and an ASU/AONL Executive Fellow in Health Innovation Leadership alumna.
She led the team that published The Nurse’s Guide to Innovation, co-authored The Innovation Roadmap: A Guide for Nurse Leaders, and has published on the impact of AI and robots on nursing practice, and authored The Nurse Managers Guide to an Intergenerational Workforce.
Kenneth S. Ramos, MD, PhD, is an accomplished physician-scientist and transformational leader, with designations in the National Academy of Sciences and National Academy of Medicine. He is recognized throughout the world for his scientific contributions in the areas of genomics, precision medicine and toxicology.
With formal training in pharmaceutical sciences, chemistry, biochemistry, pharmacology, and medicine, Dr. Ramos is helping to steer the changing landscape of medicine and healthcare. He leads several translational, clinical and educational programs that integrate diverse approaches to elucidate genomic mechanisms of disease. Dr. Ramos has provided academic, executive, administrative, and scientific leadership in genetics and genomic medicine and toxicology at several institutions, and over the course of his career has influenced the career of numerous clinicians and scientists engaged in medical, veterinary and pharmaceutical practice.
He is committed to initiatives that advance modern technological applications to improve quality of healthcare and reduce disease burden and health-associated costs.
Dr. Ramos’s research has paved the way for ground breaking research on LINE-1 retroelements and their role in chromatin remodeling, DNA damage and repair, and genetic reprogramming.
His group was the first to establish a role for retinoblastoma proteins as master regulators of epigenetic silencing of LINE-1 and later characterized novel targets for regulation of cancer cells. He is currently examining the utility of circulating LINE-1 protein as prognostic and diagnostic biomarkers of various cancer types, which combined with imaging modalities may improve precision for early cancer detection. This knowledge is also being used to develop targeted therapies for lung and liver cancer.
He serves as the Executive Director, Texas A&M Institute of Biosciences and Technology, the Alkek Chair of Medical Genetics and Professor of Medicine at Texas A&M College of Medicine. He is the Associate Vice President for Research, Texas A&M University Health Science Center
and the Assistant Vice Chancellor for Health Services, The Texas A&M University System. He also serves as a Professor of Oncology at the Houston Methodist Research Institute.
Nora Belcher is the Executive Director of the Texas e-Health Alliance, a non-profit advocacy group that she started in 2009 to give health information technology stakeholders a voice in public policy.
The Texas e-Health Alliance serves as the state's leading advocate, from local communities to the national level, for the use of information technology to improve the health care system for patients.
She is widely considered to be one of the state’s leading experts in digital health care, having worked on the issue for over 20 years in a variety of roles.
During the most recent Texas legislative session, Ms. Belcher led the passage of a number of bills related to telemedicine, telehealth and remote patient monitoring. Ms. Belcher holds a bachelor’s degree in government from the University of Texas at Austin.
Dr. Thomas J Kim lives and works in Austin, TX as Principal for AGMP Telehealth offering clinical and consulting services to organizations seeking to leverage the promise of value-based care delivery through telehealth.
He has most recently been appointed Chief Behavioral Health Officer at PRISM Health North Texas and has been privileged to support many other organizations including Austin based, Medici, as their Physician Evangelist.
Dr. Kim’s advocacy work includes serving on the TMA’s Council on Legislation, Committee on Health Information Technology, and Subcommittee on Behavioral Health. Also, he was recently appointed to the Texas Governor’s newly formed Broadband Development Council.
Dr. Kim received his BA in Philosophy from Georgetown University and MD, MPH from Tulane University. Dr. Kim continued at Tulane with a combined residency in Internal Medicine and Psychiatry and General Medicine Fellowship in Health Services Research.
THE MODERATORS
Dan Hargrove is a biotech entrepreneur and lawyer. He is the President and Co-Founder of Cancer Insight. Cancer Insight is a cutting-edge, full-service clinical Contract Research Organization whose core business is to develop, test, and bring novel immunotherapies to the market.
Working at the vanguard of immuno-oncology, Cancer Insight has an extensive network of collaborators and study sites at both academic institutions and high-volume community practices. Cancer Insight has successfully designed and executed studies involving cancer vaccines, personalized immuno-oncology products, monoclonal antibodies, oncolytic viruses, checkpoint inhibitors, therapeutic proteins, and immune modulators.
Cancer Insight employs several oncologists and physicians trained as clinical-trialists; statisticians; PhDs; a pharmacist; and other professionals trained in the art and science of clinical trial design and execution.
Mr. Hargrove is a former Army officer and professor of law. He received his B.S from Texas A&M University and his J.D. from U.T. School of Law.
He is married to Susie Hargrove, JD. They have three children (Emily, a PharmD; Jay, an engineer; and Shane, a biomedical engineering student at Texas A&M).
Greg Matthews has studied patterns of influence in healthcare for more than 15 years. At Humana, his team created the healthcare industry’s first social analytics tool. At W2O, he created the MDigitalLife analytics platform, linking the digital footprints of over 1M healthcare people and organizations around the world.
As the founder of HealthQuant, he has created an HCP influence analytics model that’s truly worthy of the digital age. Greg has helped dozens of healthcare companies to unlock their HCP strategies based on assessing "REAL Physician Influence.”
Greg is a regular public speaker, and his work has been featured in numerous top-selling business books by authors such as Charlene Li (“Open Leadership”); Bill Taylor (“Practically Radical”) and Larry Weber (“Everywhere.”) and in publications such as Forbes, Health Affairs, Business Insider, KevinMD, MedPage Today and Medical Marketing and Media.
Within the last 2 years he won both the Innovation Catalyst award (Medical Marketing & Media Magazine) and the Elite Tech-Know Geek award (PM360 Magazine). Greg is the host of the DataPoint healthcare data & analytics podcast, and advises the Mayo Clinic’s Social Media Network, the South by Southwest (SXSW) interactive conference and the Dell Medical School’s Texas Health Catalyst incubator program.
Debra Patt, M.D., PhD, MBA is a practicing oncologist, breast cancer specialist, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer research, serves on the US Oncology Research breast cancer committee, and chairs the breast cancer subsection of the pathways task force for The US Oncology Network. She is a nationally and locally recognized leader for breast cancer research.
Her expertise is in healthcare policy. She is a leader in clinical cancer informatics and involved in system innovations to enhance care delivery across a national network of oncology practices. Additionally, she serves as the Editor In Chief of the Journal of Clinical Oncology-Clinical Cancer Informatics, and leads initiatives in imaging informatics for breast cancer, clinical decision support systems, predictive analytics to reduce risk in patients with advanced cancer, telemedicine, and quality improvement.
At the onset of the COVID-19 pandemic, Dr. Patt led the rapid expansion of Texas Oncology’s telemedicine capabilities from 15 to 90 percent of providers within two weeks, which enabled the practice to better serve cancer patients while also reducing their risk of exposure amid a global pandemic.
From 2008-2015, she led healthcare informatics for The US Oncology Network and continues to lead analytics as a medical director for McKesson Specialty Health. In 2016, Dr. Patt testified before Congress to protect cancer care for Medicare beneficiaries.
Dr. Patt resides in Austin, Texas, where she is a clinical professor at Dell Medical School at The University of Texas at Austin.